Bargude Balta

Mr. Bargude Balta


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2023 in BMC Women's Health
Verified
Journal Article
Open access
PDF file
AWAbel Wubu
Abel Wubu
BBBargude Balta
Bargude Balta
ACAmsale Cherie
Amsale Cherie
KBKetema Bizuwork
Ketema Bizuwork
Background: Human papillomavirus vaccine uptake among school girls in Ethiopia was still low and uptake was majorly related to perception regarding the vaccine. This study explored school girls’ perceptions of Human papillomavirus vaccination in Addis Ababa, Ethiopia. Objectives: The main aim of this study was to explore the perception of secondary school girls towards Human Papilloma Virus vaccine in Addis Ababa, Ethiopia 2023. Methods: A qualitative research using focused group discussions were used to explore middle adolescent school girls’ perceptions of Human papillomavirus in Addis Ababa Ethiopia from March 2023-April 2023. A focus group discussion guide was employed with potential probes to achieve study objectives. A convenience sampling technique was performed to select study participants. The collected data were transcribed and translated into English and thematic analysis was done by using Atlas-Ti software version 7.5.16. Result: Two dominant themes emerged from the study; perceived benefits and potential barriers to Human papillomavirus vaccine uptake. Poor awareness, lack of family support, perception of poor vaccine quality, fear of side effects, misconceptions, and myths are potential barriers to the Human papillomavirus vaccine. Some students perceive the vaccine as important in the prevention of cervical cancer, others are not sure about the importance of the vaccine and many students think that the vaccine can cause infertility and other beliefs it can cause diseases. Conclusion: The perceived benefits of the Human papillomavirus vaccine was; it prevents cervical cancer enhance acceptability and can be an important motivation for Human papillomavirus vaccination among students. The main barriers to vaccine uptake and acceptance were; lack of awareness, misconceptions, and myths, lack of credible information sources of vaccines, perception of poor vaccine quality, Poor family support, and cultural and religious perspectives. We recommend the development of strong collaborations that work on identified challenges.

1 September 2023 in JCO Global Oncology
Verified
Journal Article
Open access
NBNetsanet Bogale
Netsanet Bogale
BBBargude Balta
Bargude Balta
GDGulema Demissie
Gulema Demissie
DGDereje Geleta
Dereje Geleta
MRMichele Rakoff
Michele Rakoff
LTLesley Taylor
Lesley Taylor
PURPOSE: The aim of this study was to explore breast cancer (BC) challenges to identify opportunities for advocacy in southern Ethiopia in 2022. METHODS: Twenty-five participants from four local districts (kebeles) in Hawassa City were selected as key contributors to future work. Semistructured in-depth interviews were held for two clinicians, two local health bureau managers, two media managers, and three religious leaders. Two focus group discussions were conducted: one included six BC survivors and a caregiver; the other included two health extension workers, three members of the Women's Development Group, two community volunteers, one kebele leader, and one traditional healer. RESULTS: To our knowledge, our study was the first time that most participants had assembled. Many referred to patients as victims and BC as a killer disease or curse. Community and religious leaders were concerned about challenges and willing to collaborate. Survivors, providers, and religious leaders were identified as key sources of information, positive messages, and leadership. CONCLUSION: Recommendations for advocacy work in Hawassa include lobbying for BC as a health priority; including BC within the health extension package; initiating programs for earlier detection; educating the community to remove stigmas of the disease and treatments; working with media to disseminate messages that are inclusive of people in remote areas and speaking different languages; improving availability, affordability, and access to care; and assisting patients with psychosocial support. A strategic collaboration between religious leaders and health care providers was identified to increase community awareness and support advocacy for patients.

7 April 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
BBBargude Balta
Bargude Balta
ADAlemayehu Delelegn
Alemayehu Delelegn
GDGulema Demissie
Gulema Demissie
BDBedilu Deribe
Bedilu Deribe
Background: Medication adherence refers to how closely a patient follows the prescribed timing and dosage of their treatment. Adherence to chemotherapy is particularly complex and multifaceted, and it can have a significant impact on the effectiveness of the therapy. In Ethiopia, non-adherence to chemotherapy is on the rise, but there has been limited research specifically on adherence to intravenous (IV) chemotherapy. Objective: This study assesses IV chemotherapy adherence and associated factors among cancer patients in the Sidama Region, southern Ethiopia. Methods: A hospital-based cross-sectional study included a purposive sample of 413 cancer patients undergoing IV chemotherapy. The Morisky Medication Adherence Scale was used to measure adherence levels. Data analysis was performed using SPSS version 26, employing descriptive statistics such as frequency distribution, mean, median, and standard deviation to describe the characteristics and magnitude of IV chemotherapy adherence. Bivariable and multivariable logistical regression analysis was conducted to identify factors associated with IV chemotherapy adherence. Result: The current study revealed that the overall magnitude of good adherence toward chemotherapy treatment among cancer patients was 176/413(42.6%), with a 95% CI of 38–47.9. The multivariable analysis identified several independent factors associated with IV chemotherapy adherence. These factors included being married (AOR = 3.2, 95% CI:1.3,8), employment as a government employee (AOR = 2.4,95% CI:1.3,4.5), availability of transportation (AOR = 5.5, 95% CI:2.1,14), Good social support (AOR = 2.1,95% CI:1.9,11.3) and having a curative goal of treatment (AOR = 1.7,95% CI:1.1,2.7). Conclusion: In the current study, the magnitude of intravenous chemotherapy adherence among patients with cancer was low compared to published national and international findings. Possible contributing factors include marital status, employment, Transportation availability, and social support. Targeted measures are needed to improve adherence and, as a result, maximize therapeutic benefits.

2 October 2023 in Cancer Reports
Verified
Journal Article
Open access
BBBargude Balta
Bargude Balta
TGTigistu Gebreyohannis
Tigistu Gebreyohannis
ETErdaw Tachbele
Erdaw Tachbele
Background: Although Ethiopia has more than 78% of leukemia cases and a significant burden of the disease, the survival of leukemia patients in the country is poorly recognized. The purpose of this study was to assess the survival and predictors of acute leukemia patients.Methods: A 5‐year retrospective cohort study was conducted including all acute Leukemia patients who visited Tikur Anbessa Specialized Hospital between January 2015 and December 2019. Data were retrieved from patient's medical records between March and April 2020. Using SPSS version 25, the Kaplan–Meier curve and Cox regression models were employed to analyze the data.Results: A total of 119 patients with acute leukemia were retrospectively evaluated for 60 months, having 196 person‐years of risk. About 46 deaths (38.7%) were recorded over the follow‐up period, giving a mortality incidence rate of 23.5 (95% CL:18–52) per 100 person‐years. The median survival time was 35 months (95% CI, 28.3–41.7). At 60 months of follow‐up, the predicted overall survival rate after diagnosis for acute leukemia was 21%. The adjusted hazard ratio for acute leukemia subtypes (aHR:4.9, 95% CI:2.3–10.4), history of relapse (aHR:3.9, 95% CI:1.0–7.9), participant age (aHR:1.25, 95% CI:1–1.75), hepatomegaly (aHR:2.7, 95% CI:1.36–5.36), and splenomegaly (aHR:2.29, 95% CI:1.2–4.4).Conclusion: The 5‐year overall survival rate was found to be 21%. The finding was remarkably lower than other published reports. Survival among acute leukemia patients was significantly associated with older age, history of relapse, hepatomegaly, splenomegaly, as well as certain subtypes. Therefore, improving early detection and initiation of treatment for all acute leukemia patients is necessary in order to improve patient's survival status.

26 August 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
BBBargude Balta
Bargude Balta
LTLesley Taylor
Lesley Taylor
NBNetsanet Bogale
Netsanet Bogale
DHDejene Hailu
Dejene Hailu
YZYasmin A. Zerhouni
Yasmin A. Zerhouni
Background: The incidence and mortality of colorectal cancer were still rising rapidly in many low-income and middle-income countries, which was linked to ongoing societal and economic status. Colorectal cancer is the leading cancer in Ethiopia with relatively lower survival. However, colorectal cancer patients’ survival time and predictors have not been well studied in Southern Ethiopia. Objective: This study aimed to assess five-year survival and predictors of mortality among colorectal cancer patients at Hawassa Comprehensive Specialized Hospital, Ethiopia. Method: Facility-based retrospective cohort study was conducted among 323 patients who visited Hawassa Comprehensive Specialized Hospital from May 1st, 2017 to April 30th, 2022. The Kaplan-Meier survival curve with the Log-rank test was used to estimate the survival time. Bivariable and multivariable Cox proportional hazards regression models were used to determine the net effect of each independent variable on time to death after diagnosis. Result: Over the 5-year observation period, the overall mortality rate was 38.5%, with an incidence density of 31 fatalities per 100 person-years observation. Survival at 1, 2, 3, 4, and 5 years was 78%, 53, 32.4%, 23.3%, and 18.7% respectively. The multivariable analysis showed that metastatic disease (AHR = 4.2, CI: 1.5–11.5), baseline carcinoembryonic antigen level ≥5ng/ml (AHR: 2.4, CI: 1.2–5.8), living in rural areas (AHR = 2.2, CI:1.03–4.8) and mucinous carcinoma (AHR = 0.33, CI: 0.13–0.87) were independent predictors of colorectal cancer mortality. Conclusion: Overall survival of colorectal cancer patients in the study was low compared to similar studies in developing and developed worlds. A significantly low survival rate was observed for patients with advanced stage, elevated carcinoembryonic antigen levels, and rural residents indicating the key role of early detection and timely initiation of treatment to improve survival and quality of life of patients with colorectal cancer.

14 January 2022
Verified
Journal Article
Open access
BBBargude Balta
Bargude Balta
ALAmanuel Fanta Lambebo
Amanuel Fanta Lambebo
Background : Female genital mutilation (FGM) is estimated to have been practiced on at least 200 million girls and women in 30 countries around the world. Clitoridoctomy is the most common type of FGM in Ethiopia. Objectives : The aim of the study was to assess the magnitude of Female Genital Mutilation and associated factors among women’s of Wolayita zone. Methods : A community-based quantitative cross-sectional study was used. Face-to-face interviews with prepared questionnaires were used to collect data. SPSS version 20 software was used to analyze the data. The prevalence of FGM was determined using descriptive statistics. The researchers utilized a bivariate and multivariate logistic regression model to find independent determinants of FGM. Result : 296 women were undergone FGM out of a total of 333, indicating that FGM is prevalent in the research area (88.9%). Age (AOR-1.86, 95% CI: 0.42-0.98) and hyperactivity (AOR: 14.595, 95% CI: 3.391-6.807) were all independently linked to FGM. Conclusion : An integrated effort administrative and surrounding community intervention to be initiated to alleviate FGM practices through empowering women, discouraging risky factors like traditions; and sensitizing parents, community members and the public focusing on the rejecting of FGM.